Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nature ; 626(7999): 574-582, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38086421

ABSTRACT

The intrinsic mechanisms that regulate neurotoxic versus neuroprotective astrocyte phenotypes and their effects on central nervous system degeneration and repair remain poorly understood. Here we show that injured white matter astrocytes differentiate into two distinct C3-positive and C3-negative reactive populations, previously simplified as neurotoxic (A1) and neuroprotective (A2)1,2, which can be further subdivided into unique subpopulations defined by proliferation and differential gene expression signatures. We find the balance of neurotoxic versus neuroprotective astrocytes is regulated by discrete pools of compartmented cyclic adenosine monophosphate derived from soluble adenylyl cyclase and show that proliferating neuroprotective astrocytes inhibit microglial activation and downstream neurotoxic astrocyte differentiation to promote retinal ganglion cell survival. Finally, we report a new, therapeutically tractable viral vector to specifically target optic nerve head astrocytes and show that raising nuclear or depleting cytoplasmic cyclic AMP in reactive astrocytes inhibits deleterious microglial or macrophage cell activation and promotes retinal ganglion cell survival after optic nerve injury. Thus, soluble adenylyl cyclase and compartmented, nuclear- and cytoplasmic-localized cyclic adenosine monophosphate in reactive astrocytes act as a molecular switch for neuroprotective astrocyte reactivity that can be targeted to inhibit microglial activation and neurotoxic astrocyte differentiation to therapeutic effect. These data expand on and define new reactive astrocyte subtypes and represent a step towards the development of gliotherapeutics for the treatment of glaucoma and other optic neuropathies.


Subject(s)
Astrocytes , Neuroprotection , Adenylyl Cyclases/metabolism , Astrocytes/cytology , Astrocytes/enzymology , Astrocytes/metabolism , Cell Differentiation , Cell Nucleus/metabolism , Cell Survival , Cyclic AMP/metabolism , Cytoplasm/metabolism , Macrophages/metabolism , Macrophages/pathology , Microglia/metabolism , Microglia/pathology , Optic Nerve Injuries/metabolism , Optic Nerve Injuries/pathology , Optic Nerve Injuries/therapy , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/metabolism , White Matter/metabolism , White Matter/pathology , Glaucoma/pathology , Glaucoma/therapy
3.
Cell Rep ; 33(9): 108464, 2020 12 01.
Article in English | MEDLINE | ID: mdl-33264616

ABSTRACT

Store-operated Orai1 calcium channels function as highly Ca2+-selective ion channels and are broadly expressed in many tissues including the central nervous system, but their contributions to cognitive processing are largely unknown. Here, we report that many measures of synaptic, cellular, and behavioral models of learning are markedly attenuated in mice lacking Orai1 in forebrain excitatory neurons. Results with focal glutamate uncaging in hippocampal neurons support an essential role of Orai1 channels in amplifying NMDA-receptor-induced dendritic Ca2+ transients that drive activity-dependent spine morphogenesis and long-term potentiation at Schaffer collateral-CA1 synapses. Consistent with these signaling roles, mice lacking Orai1 in pyramidal neurons (but not interneurons) exhibit striking deficits in working and associative memory tasks. These findings identify Orai1 channels as essential regulators of dendritic spine Ca2+ signaling, synaptic plasticity, and cognition.


Subject(s)
Calcium Signaling , Calcium/metabolism , Dendritic Spines/metabolism , Glutamic Acid/metabolism , Animals , Hippocampus/metabolism , Memory , Mice , ORAI1 Protein , Pyramidal Cells/metabolism , Signal Transduction
4.
Sci Signal ; 12(582)2019 05 21.
Article in English | MEDLINE | ID: mdl-31113852

ABSTRACT

Astrocytes are the major glial subtype in the brain and mediate numerous functions ranging from metabolic support to gliotransmitter release through signaling mechanisms controlled by Ca2+ Despite intense interest, the Ca2+ influx pathways in astrocytes remain obscure, hindering mechanistic insights into how Ca2+ signaling is coupled to downstream astrocyte-mediated effector functions. Here, we identified store-operated Ca2+ release-activated Ca2+ (CRAC) channels encoded by Orai1 and STIM1 as a major route of Ca2+ entry for driving sustained and oscillatory Ca2+ signals in astrocytes after stimulation of metabotropic purinergic and protease-activated receptors. Using synaptopHluorin as an optical reporter, we showed that the opening of astrocyte CRAC channels stimulated vesicular exocytosis to mediate the release of gliotransmitters, including ATP. Furthermore, slice electrophysiological recordings showed that activation of astrocytes by protease-activated receptors stimulated interneurons in the CA1 hippocampus to increase inhibitory postsynaptic currents on CA1 pyramidal cells. These results reveal a central role for CRAC channels as regulators of astrocyte Ca2+ signaling, gliotransmitter release, and astrocyte-mediated tonic inhibition of CA1 pyramidal neurons.


Subject(s)
Astrocytes/physiology , Calcium Signaling/physiology , Calcium/metabolism , GABAergic Neurons/physiology , ORAI1 Protein/metabolism , Stromal Interaction Molecule 1/metabolism , Adenosine Triphosphate/metabolism , Animals , Astrocytes/cytology , Astrocytes/metabolism , CA1 Region, Hippocampal/cytology , CA1 Region, Hippocampal/metabolism , Calcium Release Activated Calcium Channels/genetics , Calcium Release Activated Calcium Channels/metabolism , Cells, Cultured , Exocytosis/physiology , Female , GABAergic Neurons/cytology , Male , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , ORAI1 Protein/genetics , Pyramidal Cells/cytology , Pyramidal Cells/physiology , Stromal Interaction Molecule 1/genetics , Synaptic Transmission/physiology
5.
Cell Calcium ; 59(2-3): 124-34, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27020657

ABSTRACT

Calcium (Ca(2+)) signaling has essential roles in the development of the nervous system from neural induction to the proliferation, migration, and differentiation of neural cells. Ca(2+) signaling pathways are shaped by interactions among metabotropic signaling cascades, intracellular Ca(2+) stores, ion channels, and a multitude of downstream effector proteins that activate specific genetic programs. The temporal and spatial dynamics of Ca(2+) signals are widely presumed to control the highly diverse yet specific genetic programs that establish the complex structures of the adult nervous system. Progress in the last two decades has led to significant advances in our understanding of the functional architecture of Ca(2+) signaling networks involved in neurogenesis. In this review, we assess the literature on the molecular and functional organization of Ca(2+) signaling networks in the developing nervous system and its impact on neural induction, gene expression, proliferation, migration, and differentiation. Particular emphasis is placed on the growing evidence for the involvement of store-operated Ca(2+) release-activated Ca(2+) (CRAC) channels in these processes.


Subject(s)
Calcium Signaling , Calcium/metabolism , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neurogenesis , Neurons/cytology , Neurons/metabolism , Animals , Cell Movement , Cell Proliferation , Humans
6.
Nat Neurosci ; 16(10): 1417-25, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24036914

ABSTRACT

Formation of appropriate synaptic connections is critical for proper functioning of the brain. After initial synaptic differentiation, active synapses are stabilized by neural activity-dependent signals to establish functional synaptic connections. However, the molecular mechanisms underlying activity-dependent synapse maturation remain to be elucidated. Here we show that activity-dependent ectodomain shedding of signal regulatory protein-α (SIRPα) mediates presynaptic maturation. Two target-derived molecules, fibroblast growth factor 22 and SIRPα, sequentially organize the glutamatergic presynaptic terminals during the initial synaptic differentiation and synapse maturation stages, respectively, in the mouse hippocampus. SIRPα drives presynaptic maturation in an activity-dependent fashion. Remarkably, neural activity cleaves the extracellular domain of SIRPα, and the shed ectodomain in turn promotes the maturation of the presynaptic terminal. This process involves calcium/calmodulin-dependent protein kinase, matrix metalloproteinases and the presynaptic receptor CD47. Finally, SIRPα-dependent synapse maturation has an impact on synaptic function and plasticity. Thus, ectodomain shedding of SIRPα is an activity-dependent trans-synaptic mechanism for the maturation of functional synapses.


Subject(s)
Excitatory Postsynaptic Potentials/physiology , Receptors, Immunologic/physiology , Synapses/physiology , Synapses/ultrastructure , Animals , Cells, Cultured , Female , HEK293 Cells , Hippocampus/physiology , Hippocampus/ultrastructure , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Organ Culture Techniques , Protein Structure, Tertiary/physiology
7.
Nature ; 465(7299): 783-7, 2010 Jun 10.
Article in English | MEDLINE | ID: mdl-20505669

ABSTRACT

The differential formation of excitatory (glutamate-mediated) and inhibitory (GABA-mediated) synapses is a critical step for the proper functioning of the brain. An imbalance in these synapses may lead to various neurological disorders such as autism, schizophrenia, Tourette's syndrome and epilepsy. Synapses are formed through communication between the appropriate synaptic partners. However, the molecular mechanisms that mediate the formation of specific synaptic types are not known. Here we show that two members of the fibroblast growth factor (FGF) family, FGF22 and FGF7, promote the organization of excitatory and inhibitory presynaptic terminals, respectively, as target-derived presynaptic organizers. FGF22 and FGF7 are expressed by CA3 pyramidal neurons in the hippocampus. The differentiation of excitatory or inhibitory nerve terminals on dendrites of CA3 pyramidal neurons is specifically impaired in mutants lacking FGF22 or FGF7. These presynaptic defects are rescued by postsynaptic expression of the appropriate FGF. FGF22-deficient mice are resistant to epileptic seizures, and FGF7-deficient mice are prone to them, as expected from the alterations in excitatory/inhibitory balance. Differential effects of FGF22 and FGF7 involve both their distinct synaptic localizations and their use of different signalling pathways. These results demonstrate that specific FGFs act as target-derived presynaptic organizers and help to organize specific presynaptic terminals in the mammalian brain.


Subject(s)
Cell Differentiation , Excitatory Postsynaptic Potentials/physiology , Fibroblast Growth Factor 7/metabolism , Fibroblast Growth Factors/metabolism , Inhibitory Postsynaptic Potentials/physiology , Synapses/classification , Synapses/metabolism , Animals , Cells, Cultured , Dendrites/metabolism , Disease Susceptibility , Epilepsy/chemically induced , Epilepsy/genetics , Epilepsy/physiopathology , Fibroblast Growth Factor 7/deficiency , Fibroblast Growth Factor 7/genetics , Fibroblast Growth Factors/deficiency , Fibroblast Growth Factors/genetics , Gene Expression Profiling , Glutamic Acid/metabolism , Hippocampus/cytology , Hippocampus/embryology , Hippocampus/metabolism , Hippocampus/pathology , In Situ Hybridization , Kindling, Neurologic , Mice , Mice, Knockout , Miniature Postsynaptic Potentials/physiology , Presynaptic Terminals/classification , Presynaptic Terminals/metabolism , Presynaptic Terminals/pathology , Presynaptic Terminals/ultrastructure , Pyramidal Cells/cytology , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , Receptors, Fibroblast Growth Factor/metabolism , Seizures/chemically induced , Seizures/genetics , Seizures/radiotherapy , Synapses/pathology , Synapses/ultrastructure , Synaptic Transmission , Synaptic Vesicles/metabolism , Synaptic Vesicles/pathology , Synaptic Vesicles/ultrastructure , gamma-Aminobutyric Acid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...